SHEBA MEDICAL CENTER
๐ฟ๐ฆSouth Africa
- Country
- ๐ฟ๐ฆSouth Africa
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sheba.co.il
Potentiation of Chemotherapy in Brain Tumors by Zinc
Not Applicable
- Conditions
- Newly Diagnosed Glioblastoma Who Underwent at Least Partial Resection of the Tumor Surgically
- Interventions
- Dietary Supplement: zinc and ascorbate
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2020-07-28
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04488783
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop Atherosclerosis
- Conditions
- Atherosclerosis
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04487223
- Locations
- ๐ฎ๐ฑ
Lipid center, Tel HaShomer, Israel
Unannounced Meal Handling of Advanced Closed Loop Insulin Delivery in Monitored Condition
Not Applicable
Completed
- Conditions
- type1diabetes
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2022-05-12
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT04479826
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Tel-Hashomer, Israel
Study on Inferior Vena Cava Thrombosis
Not yet recruiting
- Conditions
- Inferior Vena Cava Thrombosis
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT04470986
Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19
- Conditions
- COVID 19
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2021-11-29
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT04438863
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT04429711
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat-Gan, Israel
Ultra-Low Dose Computed Tomography For Diagnosis And Follow-Up Of Patients With Diffuse Parenchymal Lung Disease (DPLD)
- Conditions
- Diffuse Parenchymal Lung Disease
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04392726
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients
Phase 2
- Conditions
- Metastatic Urothelial Carcinoma
- Interventions
- Procedure: Tumor Infiltrating Lymphocytes (TIL)
- First Posted Date
- 2020-05-11
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT04383067
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Tamsulosin for Thyroid Lid Retraction
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT04359979
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Tel Hashomer, Israel
Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus
Phase 3
- Conditions
- COVID - 19
- Interventions
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT04355052
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Tel HaShomer, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath